COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab

被引：29
|
作者：
Foerster-Ruhrmann, Ulrike [1 ,2 ,3 ,4 ]
Szczepek, Agnieszka J. [1 ,2 ,3 ,4 ]
Bachert, Claus [5 ,6 ]
Olze, Heidi [1 ,2 ,3 ,4 ]
机构：
[1] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Berlin Inst Hlth, Berlin, Germany
[5] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium
[6] Univ Ghent, Dept Otorhinolaryngol, Ghent, Belgium
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2020年 / 146卷 / 01期
关键词：
D O I：
10.1016/j.jaci.2020.05.005
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：218 / 220
页数：3
相关论文
共 50 条
  • [1] Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma
    Amaral, L.
    Pereira, A. M.
    Braganca, M.
    Placido, J. L.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2024, 141 (01) : 55 - 56
  • [2] Assessment of patient satisfaction with dupilumab for chronic rhinosinusitis with nasal polyps
    Oka, Aiko
    Kanai, Kengo
    Matsune, Shoji
    Hosoya, Kei
    Komachi, Taro
    Murakami, Ryosuke
    Okubo, Kimihiro
    Hirano, Kojiro
    Suzaki, Isao
    Shimura, Tomotaka
    Tokudome, Takatoshi
    Kanzaki, Sho
    Wakabayashi, Ken-ichiro
    Ozawa, Hiroyuki
    Okamoto, Yasuhide
    Kondo, Kenji
    Nishijima, Hironobu
    Nishijima, Ami
    Okano, Mitsuhiro
    ALLERGY, 2025, 80 (02) : 614 - 616
  • [3] Chronic rhinosinusitis with nasal polyps Extension of the Dupilumab therapy intervals
    Appel, H.
    Hahn, J.
    ALLERGOLOGIE, 2023, 46 (08) : 548 - 548
  • [4] Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
    Hellings, Peter W.
    Peters, Anju T.
    Chaker, Adam M.
    Heffler, Enrico
    Zhang, Haixin
    Praestgaard, Amy
    Nash, Scott
    Khan, Asif H.
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (07) : 958 - 962
  • [5] Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
    Sheridan M. Hoy
    Drugs, 2020, 80 : 711 - 717
  • [6] Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
    Hoy, Sheridan M.
    DRUGS, 2020, 80 (07) : 711 - 717
  • [7] Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma A prospective study
    Tajiri, Tomoko
    Suzuki, Motohiko
    Nishiyama, Hirono
    Ozawa, Yoshiyuki
    Kurokawa, Ryota
    Ito, Keima
    Fukumitsu, Kensuke
    Mori, Yuta
    Kanemitsu, Yoshihiro
    Fukuda, Satoshi
    Uemura, Takehiro
    Ohkubo, Hirotsugu
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Oguri, Tetsuya
    Iwasaki, Shinichi
    Niimi, Akio
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (05)
  • [8] Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps*
    Kemp, Pieter
    Otten, Josje J.
    Adriaensen, Gwijde F. J. P. M.
    Benoist, Linda B. L.
    Cornet, Marjolein E.
    Hoven, D. Rienk
    Rinia, Bas
    Verkest, Valerie
    Fokkens, Wytske J.
    Reitsma, Sietze
    RHINOLOGY, 2024, 62 (02) : 202 - 207
  • [9] Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps
    Hopkins, Claire
    Mullol, Joaquim
    Khan, Asif H.
    Lee, Stella E.
    Wagenmann, Martin
    Hellings, Peter
    Fokkens, Wytske
    Msihid, Jerome
    Nair, Radhika
    Kamat, Siddhesh
    Nash, Scott
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (04) : 1173 - 1182
  • [10] Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps
    Lane, Andrew
    Mullol, Joaquim
    Hopkins, Claire
    Fokkens, Wytske
    Lee, Stella
    Khan, Asif
    Msihid, Jerome
    Nash, Scott
    Siddiqui, Shahid
    Mujumdar, Urvi
    Kamat, Siddhesh
    Rowe, Paul
    Deniz, Yamo
    Jacob-Nara, Juby
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB144 - AB144
12345